Saint Petersburg, FL, June 24, 2015 (GLOBE NEWSWIRE) -- FutureWorld Corp. (OTC: FWDG), a cannabis technology accelerator and a leading provider of advanced technologies and solutions to the global cannabis industry, announced today that it has concluded the incubation of Bioceutical Sciences™ after months of vetting and numerous development processes. Bioceutical Sciences™ will become the newest addition to its family of companies as a wholly owned subsidiary.
Bioceutical Sciences™, as a new avant-garde laboratory, is a professionally run production, formulation, and analytics lab working on their ISO/IEC 17025:9001 and CGMP certifications to establish themselves as one of the most premier cannabis related research and production labs in the country. A well-seasoned team mentored by some of the most prominent cutting-edge scientists from around the world will be bringing these and many more processes to the fore:
- Water-soluble Cannabidiol
- Convergence, high pressure liquid, gas, and thin layer chromatography methods
- Mass Spectrometry (molecular mass)
- Liposomal formulations
- Electron microscopy (SEM and TEM)
- Supercritical extraction and chromatography
- Research consultation
It has taken over a year of due diligence, ironing out every detail regarding linear and nonlinear obstacles; creating doctoral connections in every division of laboratory control and procedure to ensure proper operation of a state-of-the-art laboratory. These factors ensure that Bioceutical Sciences™ follows proper manufacturing, analytic, and production standards and practices for continuous operation. Currently Bioceutical Sciences™ manufactures, designs, processes and develops the following:
- (Hemp) CBD oil testing and analytics
- Raw (Hemp) CBD oil
- Processed (Hemp) CBD oil with multi-variation in strength and quality
- (Hemp) CBD oil formulations such as Vapes, Tinctures, Pills, Capsules, Edibles, and custom formulations for nutraceutical companies
Bioceutical Sciences™ products and services are also available as Private label to retailers, wholesalers and distributors worldwide.
Bioceutical Sciences™ has also been instrumental in developing unique products for CB Scientific, and URVape and will continue to do so in the foreseeable future.
About FutureWorld Corp.
FutureWorld (OTC: FWDG), a Delaware corporation, is a leading provider of advanced technologies and solutions to the global cannabis industry. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of cannabis related products and services, such as industrial Hemp. FutureWorld, through its subsidiaries, provides personal and professional THC and CBD test kits, pharmaceutical grade CBD oil solutions, SafeVape vaporizers, smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal cannabis. Our wireless agricultural smart sensor networks offer precision to the agriculture, irrigation systems, and greenhouses for the global cannabis and hemp industry. FutureWorld and its subsidiaries do not grow, distribute or sell marijuana.
As the only Cannabis Technology Accelerator, FutureWorld will incubate and fund leading technologies, products, and services for Cannabis industry (Industrial Hemp) for foreseeable future; bringing value to its core and its shareholders.
To request further information about FutureWorld, please email us at info@futureworldcorp.com, log onto our website at http://www.futureworldcorp.com or visit us at our Facebook page facebook.com/futureworldenergy or on Twitter @futureworldinc.
Forward-Looking Statements
This press release may contain forward-looking statements covered within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements relate to, among other things, plans and timing for the introduction or enhancement of our services and products, statements about future market conditions, supply and demand conditions, and other expectations, intentions and plans contained in this press release that are not historical fact and involve risks and uncertainties. Our expectations regarding future revenues depend upon our ability to develop and supply products and services that we may not produce today and that meet defined specifications. When used in this press release, the words "plan," "expect," "believe," and similar expressions generally identify forward-looking statements. These statements reflect our current expectations. They are subject to a number of risks and uncertainties, including, but not limited to, changes in technology and changes in pervasive markets. This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.